GZMB and neoplasm: In addition, evidence also indicates that B cells may have antitumor activity, which is mediated by killing of tumor cells through expression of TNFs/receptor proteins or production of granzyme B (28), IL12-mediated activation of NK cells (29), or antibody-dependent cell-mediated cytotoxicity (30).